Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.47 |
| ▸ | MYC | P01106 | 1/20 | 0.47 |
| ▸ | TTR | P02766 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | CDC25B | P30305 | 1/20 | 0.43 |
| ▸ | APAF1 | O14727 | 2/20 | 0.42 |
| ▸ | TDP2 | O95551 | 2/20 | 0.42 |
| ▸ | PLCG1 | P19174 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | TERT | O14746 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28837581 | 0.97 | SMN1; SMN2 (0.46) | SMN1; SMN2TSHRPGAM1MYCTTR | |
| SCHEMBL29700277 | 0.89 | PGAM1 (0.44) | SMN1; SMN2TSHRPGAM1MYCTTR | |
| SCHEMBL6155652 | 0.89 | PGAM1 (0.44) | SMN1; SMN2TSHRPGAM1MYCTTR | |
| SCHEMBL27914240 | 0.87 | PGAM1 (0.43) | SMN1; SMN2TSHRPGAM1MYCTTR | |
| SCHEMBL8949303 | 0.87 | PTGS2 (0.47) | SMN1; SMN2TSHRPGAM1MYCTTR | |
| SCHEMBL776011 | 0.87 | NPSR1 (0.43) | SMN1; SMN2TSHRPGAM1MYCTTR | |
| SCHEMBL2593808 | 0.87 | PGAM1 (0.40) | SMN1; SMN2TSHRPGAM1MYCTTR | |
| SCHEMBL3886759 | 0.87 | MYC (0.47) | SMN1; SMN2TSHRPGAM1MYCTTR | |
| SCHEMBL232659 | 0.85 | CASP1 (0.47) | SMN1; SMN2TSHRPGAM1MYCTTR | |
| SCHEMBL29743050 | 0.85 | CASP1 (0.47) | SMN1; SMN2TSHRPGAM1MYCTTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3813786-A1 | COMPOSITIONS COMPRISING SILICON DIOXIDE-BASED PARTICLES INCLUDING ONE OR MORE AGENTS | Colabs International Corporation (US) | 2021-05-05 | — | — | EP | claimed |
| EP-3180373-B1 | BIOMATERIAL WITH REDUCED INFLAMMATORY RESPONSE | GOVERNING COUNCIL UNIV TORONTO (CA) | 2021-04-07 | — | — | EP | claimed |
| US-10629953-B2 | Lithium ion secondary battery | ENVISION AESC JAPAN LTD. (JP) | 2020-04-21 | — | — | US | claimed |
| EP-2638544-B1 | PHOTOPOLYMER FORMULATION FOR PRODUCING HOLOGRAPHIC MEDIA HAVING HIGHLY CROSS-LINKED MATRIX POLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2018-12-26 | — | — | EP | claimed |
| EP-3413981-A1 | COMPOSITIONS CONTAINING A CELLULOSE DERIVED CAPSULE WITH A SUNSCREEN ACTIVE AGENT | Colabs International Corporation (US) | 2018-12-19 | — | — | EP | claimed |
| WO-2017139701-A1 | COMPOSITIONS CONTAINING A CELLULOSE DERIVED CAPSULE WITH A SUNSCREEN ACTIVE AGENT | CoLabs International Corporation (US) | 2017-08-17 | — | — | WO | claimed |
| EP-3180373-A1 | BIOMATERIAL WITH REDUCED INFLAMMATORY RESPONSE | The Governing Council of the University of Toronto (CA) | 2017-06-21 | — | — | EP | claimed |
| CN-106356561-A | Overcharge-preventing electrolyte and lithium ion battery | 宁德时代新能源科技股份有限公司 | 2017-01-25 | — | — | CN | claimed |
| CN-105111979-B | Environment-friendly type antibiotic fire-retardant TPE carpet back-adhesive powder and preparation method thereof | 安徽雄亚塑胶科技有限公司 | 2016-10-05 | — | — | CN | claimed |
| US-20160237073-A1 | Novel Polymorphs and Salts | GLAXO GROUP LTD (GB) | 2016-08-18 | — | — | US | claimed |
| WO-2006005444-A1 | CATIONIC METAL COMPLEXES FOR USE AS LIGHT-ABSORBING COMPOUNDS IN THE INFORMATION LAYER OF OPTICAL DATA CARRIERS | LANXESS DEUTSCHLAND GMBH (DE) | 2006-01-19 | — | — | WO | claimed |
| US-6767481-B2 | AT LEAST ONE REDUCIBLE AND AT LEAST ONE OXIDIZABLE SUBSTANCE OX2 AND RED1, RESPECTIVELY, WHICH ARE LINKED TO ONE ANOTHER VIA A BRIDGE | BAYER AKTIENGESELLSCHAFT (DE) | 2004-07-27 | — | — | US | claimed |
| US-20020197486-A1 | Electrochromic system with coupled RED-OX system and special anions | BERNETH HORST (DE) | 2002-12-26 | — | — | US | claimed |
| US-6417951-B1 | ELECTROLYTIC CELLS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-07-09 | — | — | US | claimed |
| EP-1015524-A1 | ELECTROCHROMIC SYSTEM WITH COUPLED RED-OX SYSTEM AND SPECIAL ANIONS | BAYER AG (DE) | 2000-07-05 | — | — | EP | claimed |
| WO-1999009111-A1 | ELECTROCHROMIC SYSTEM WITH COUPLED RED-OX SYSTEM AND SPECIAL ANIONS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-02-25 | — | — | WO | claimed |
| WO-1988009783-A1 | POLYMERIC ULTRAVIOLET LIGHT ABSORBERS | BIOPOLYMERS LIMITED (AU) | 1988-12-15 | — | — | WO | claimed |
| EP-0032072-B1 | SURFACTANT COMPOSITIONS USEFUL IN ENHANCED OIL RECOVERY PROCESSES | THE DOW CHEMICAL COMPANY (US) | 1983-05-18 | — | — | EP | claimed |
| EP-0001629-B1 | WATER-SOLUBLE, FIBRE-REACTIVE, GREEN AZO-PHTHALOCYANINE DYESTUFFS, THEIR PREPARATION AND THEIR USE | CASSELLA Aktiengesellschaft (DE) | 1981-08-12 | — | — | EP | claimed |
| US-4038031-A | REACTION WITH DIAZONIUM COMPOUND | MILES LABORATORIES, INC. (US) | 1977-07-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160237073-A1 | Novel Polymorphs and Salts | PRKDC, PRKACA, MAP3K20 | SMN1; SMN2 4783/4885TSHR 3265/4885PGAM1 1518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.